Avalon Pharma stock tests key resistance levels amid signs of increased buying momentum

The share of Middle East Pharmaceutical Industries "Avalon Pharma" has attempted to break through a key resistance level at 63.50 riyals, supported by improved buying momentum and increased liquidity. After periods of selling pressure and decline, the stock is beginning to form rising lows and is testing support levels between 60.30 and 60.80 riyals, with expectations of potentially reaching areas between 65.85 and 67.45 riyals if it manages to close above 64.50 riyals. Technical performance indicates a significant shift in trend from previous declines toward a possible upward movement.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل